retatrutide parkinson's clinical trial Reta clinical trial data & dosing — a must read Retatrutide (Reta) isn' A Big Week for GLP-1
Description
Overall, Lilly continues to look like the strongest player in the GLP-1 arms race
Based on the evidence, all forms of systemic estrogen appear to help with those vasomotor symptoms when compared to placebo
It is important to note that there is no established link between Mounjaro and increased sweet cravings specifically, and individual experiences vary widely
In head-to-head comparisons, higher doses of oral formulations can approach the efficacy of some injectable options
If a treatment is pro-growth, that should be part of the conversation
